Decoding type I and III interferon signalling during viral infection
暂无分享,去创建一个
[1] Tsung-Han Hsieh,et al. Proteomic analysis for Type I interferon antagonism of Japanese encephalitis virus NS5 protein , 2013, Proteomics.
[2] H. Ebihara,et al. Antagonism of Type I Interferon Responses by New World Hantaviruses , 2010, Journal of Virology.
[3] P. Zhou,et al. Contraction of the type I IFN locus and unusual constitutive expression of IFN-α in bats , 2016, Proceedings of the National Academy of Sciences.
[4] A. Cheng,et al. Innate Immune Evasion Mediated by Flaviviridae Non-Structural Proteins , 2017, Viruses.
[5] K. Garcia,et al. Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation , 2012, Immunological reviews.
[6] Haitao Guo,et al. Identification of Five Interferon-Induced Cellular Proteins That Inhibit West Nile Virus and Dengue Virus Infections , 2010, Journal of Virology.
[7] E. Zúñiga,et al. Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling. , 2005, Immunity.
[8] C. Rice,et al. IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage , 2013, The EMBO journal.
[9] S. Best. The Many Faces of the Flavivirus NS5 Protein in Antagonism of Type I Interferon Signaling , 2016, Journal of Virology.
[10] R. Means,et al. Mitochondrial DNA Stress Primes the Antiviral Innate Immune Response , 2014, Nature.
[11] P. Hulpiau,et al. Mx Proteins: Antiviral Gatekeepers That Restrain the Uninvited , 2013, Microbiology and Molecular Reviews.
[12] Evita T. Sadimin,et al. Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection In Vivo , 2017, mBio.
[13] Hiroki Sato,et al. Nipah and Hendra Virus Nucleoproteins Inhibit Nuclear Accumulation of Signal Transducer and Activator of Transcription 1 (STAT1) and STAT2 by Interfering with Their Complex Formation , 2017, Journal of Virology.
[14] Mamta Chawla-Sarkar,et al. Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2. , 2003, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[15] T. Pisitkun,et al. Comprehensive Proteomics Identification of IFN-λ3-regulated Antiviral Proteins in HBV-transfected Cells* , 2018, Molecular & Cellular Proteomics.
[16] G. Hartmann,et al. Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5′-diphosphates , 2014, Nature.
[17] A. Lewis-Antes,et al. IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex , 2003, Nature Immunology.
[18] S. Kotenko,et al. Interferon‐&lgr; Mediates Non‐redundant Front‐Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness , 2017, Immunity.
[19] L. Prokunina-Olsson,et al. IFN-λ4 Attenuates Antiviral Responses by Enhancing Negative Regulation of IFN Signaling , 2017, The Journal of Immunology.
[20] Michael Gale,et al. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA , 2008, Nature.
[21] M. Jantsch,et al. Rapid and dynamic transcriptome regulation by RNA editing and RNA modifications , 2016, The Journal of cell biology.
[22] M. Shiffman,et al. Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection , 2010, Hepatology.
[23] G. Stark,et al. Complex modulation of cell type-specific signaling in response to type I interferons. , 2006, Immunity.
[24] G. Moseley,et al. Interaction of rabies virus P-protein with STAT proteins is critical to lethal rabies disease. , 2014, The Journal of infectious diseases.
[25] W. Windsor,et al. Crystal structure of a complex between interferon-γ and its soluble high-affinity receptor , 1995, Nature.
[26] A. García-Sastre,et al. The interferon signaling antagonist function of yellow fever virus NS5 protein is activated by type I interferon. , 2014, Cell host & microbe.
[27] C. Rice,et al. Interferon-stimulated genes and their antiviral effector functions , 2011, Current Opinion in Virology.
[28] Zhijian J. Chen,et al. DNA-induced liquid phase condensation of cGAS activates innate immune signaling , 2018, Science.
[29] Thao Nguyen,et al. The interferons and their receptors—distribution and regulation , 2012, Immunology and cell biology.
[30] Roger Williams,et al. Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients , 2017, Front. Immunol..
[31] B. Pulendran,et al. Zika Virus Antagonizes Type I Interferon Responses during Infection of Human Dendritic Cells , 2017, PLoS pathogens.
[32] Arun K. Ghosh,et al. Deubiquitinating and Interferon Antagonism Activities of Coronavirus Papain-Like Proteases , 2010, Journal of Virology.
[33] C. V. van Eijck,et al. Influence of type-I Interferon receptor expression level on the response to type-I Interferons in human pancreatic cancer cells , 2014, Journal of cellular and molecular medicine.
[34] T. Giese,et al. RNA helicase retinoic acid-inducible gene I as a sensor of Hantaan virus replication. , 2011, The Journal of general virology.
[35] C. D. Krause,et al. Interferons, interferon‐like cytokines, and their receptors , 2004, Immunological reviews.
[36] G. Schreiber. The molecular basis for differential type I interferon signaling , 2017, The Journal of Biological Chemistry.
[37] Mamta Chawla-Sarkar,et al. Novel Growth and Death Related Interferon-Stimulated Genes (ISGs) in Melanoma: Greater Potency of IFN-β Compared with IFN-α2 , 2003 .
[38] T. Kepler,et al. The Egyptian Rousette Genome Reveals Unexpected Features of Bat Antiviral Immunity , 2018, Cell.
[39] L. Prokunina-Olsson,et al. IFN-λ4: the paradoxical new member of the interferon lambda family. , 2014, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[40] S. Barik,et al. Respiratory Syncytial Virus Nonstructural Proteins Decrease Levels of Multiple Members of the Cellular Interferon Pathways , 2009, Journal of Virology.
[41] T. Wolff,et al. Activation of the Antiviral Kinase PKR and Viral Countermeasures , 2009, Viruses.
[42] C. Rice,et al. Genetic Variation at IFNL4 Influences Extrahepatic Interferon-Stimulated Gene Expression in Chronic HCV Patients , 2018, The Journal of infectious diseases.
[43] C. Rice,et al. The IFN‐&lgr;‐IFN‐&lgr;R1‐IL‐10R&bgr; Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity , 2017, Immunity.
[44] Barbara Rehermann,et al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus , 2013, Nature Genetics.
[45] S. Kakinuma,et al. Hepatitis C virus NS4B protein targets STING and abrogates RIG‐I–mediated type I interferon‐dependent innate immunity , 2013, Hepatology.
[46] S. Schwartz,et al. TNFα-senescence initiates a STAT-dependent positive feedback loop, leading to a sustained interferon signature, DNA damage, and cytokine secretion , 2017, Aging.
[47] C. Horvath,et al. Hendra Virus V Protein Inhibits Interferon Signaling by Preventing STAT1 and STAT2 Nuclear Accumulation , 2003, Journal of Virology.
[48] J. Lindenmann,et al. Virus interference. I. The interferon , 1957, Proceedings of the Royal Society of London. Series B - Biological Sciences.
[49] K. Takeuchi,et al. The STAT2 Activation Process Is a Crucial Target of Sendai Virus C Protein for the Blockade of Alpha Interferon Signaling , 2003, Journal of Virology.
[50] J. Torchia,et al. Adenovirus evasion of interferon-mediated innate immunity by direct antagonism of a cellular histone posttranslational modification. , 2012, Cell host & microbe.
[51] N. Kato,et al. Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity. , 2013, Journal of hepatology.
[52] A. García-Sastre,et al. Dengue Virus Co-opts UBR4 to Degrade STAT2 and Antagonize Type I Interferon Signaling , 2013, PLoS pathogens.
[53] Diego Jaitin,et al. The Stability of the Ternary Interferon-Receptor Complex Rather than the Affinity to the Individual Subunits Dictates Differential Biological Activities* , 2008, Journal of Biological Chemistry.
[54] Q. Ding,et al. Species-specific disruption of STING-dependent antiviral cellular defenses by the Zika virus NS2B3 protease , 2018, Proceedings of the National Academy of Sciences.
[55] D. Lenschow,et al. The Antiviral Activities of ISG15 , 2013, Journal of Molecular Biology.
[56] N. Reich,et al. The Pathogenic NY-1 Hantavirus G1 Cytoplasmic Tail Inhibits RIG-I- and TBK-1-Directed Interferon Responses , 2006, Journal of Virology.
[57] S. Beinke,et al. IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment , 2016, EMBO molecular medicine.
[58] C. Schindler,et al. Suppressor of Cytokine Signaling (SOCS) 1 Inhibits Type I Interferon (IFN) Signaling via the Interferon α Receptor (IFNAR1)-associated Tyrosine Kinase Tyk2* , 2011, The Journal of Biological Chemistry.
[59] B. Williams,et al. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. , 1999, Virology.
[60] Jianguo Wu,et al. HERP Binds TBK1 To Activate Innate Immunity and Repress Virus Replication in Response to Endoplasmic Reticulum Stress , 2017, The Journal of Immunology.
[61] Anthony A. Hyman,et al. Biomolecular condensates: organizers of cellular biochemistry , 2017, Nature Reviews Molecular Cell Biology.
[62] Jianfei Chen,et al. The papain-like protease of porcine epidemic diarrhea virus negatively regulates type I interferon pathway by acting as a viral deubiquitinase. , 2013, The Journal of general virology.
[63] Pei-Yong Shi,et al. NS5 of Dengue Virus Mediates STAT2 Binding and Degradation , 2009, Journal of Virology.
[64] R. Lamb,et al. The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. , 2001, Virology.
[65] C. Horvath,et al. STAT2 Is a Primary Target for Measles Virus V Protein-Mediated Alpha/Beta Interferon Signaling Inhibition , 2008, Journal of Virology.
[66] A. Pichlmair,et al. RIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5'-Phosphates , 2006, Science.
[67] S. Aguirre,et al. DENV Inhibits Type I IFN Production in Infected Cells by Cleaving Human STING , 2012, PLoS pathogens.
[68] Lin‐Fa Wang,et al. Bats and their virome: an important source of emerging viruses capable of infecting humans , 2012, Current Opinion in Virology.
[69] K. Błaszczyk,et al. A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses , 2018, Front. Immunol..
[70] T. Wolff,et al. Viral targeting of the interferon-{beta}-inducing Traf family member-associated NF-{kappa}B activator (TANK)-binding kinase-1. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[71] Bernd Fischer,et al. Dengue Virus Perturbs Mitochondrial Morphodynamics to Dampen Innate Immune Responses , 2016, Cell Host & Microbe.
[72] T. Briese,et al. Z Proteins of New World Arenaviruses Bind RIG-I and Interfere with Type I Interferon Induction , 2009, Journal of Virology.
[73] M. Heim,et al. SOCS1 is an inducible negative regulator of interferon λ (IFN-λ)–induced gene expression in vivo , 2017, The Journal of Biological Chemistry.
[74] G. Schröder,et al. Structure of myxovirus resistance protein a reveals intra- and intermolecular domain interactions required for the antiviral function. , 2011, Immunity.
[75] H. Field,et al. Bats: Important Reservoir Hosts of Emerging Viruses , 2006, Clinical Microbiology Reviews.
[76] S. Kotenko,et al. Interferon-lambda: a new addition to an old family. , 2010, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[77] anonymous,et al. Comprehensive review , 2019 .
[78] Maxim N. Artyomov,et al. An Immunocompetent Mouse Model of Zika Virus Infection. , 2018, Cell host & microbe.
[79] Diego Jaitin,et al. Inquiring into the Differential Action of Interferons (IFNs): an IFN-α2 Mutant with Enhanced Affinity to IFNAR1 Is Functionally Similar to IFN-β , 2006, Molecular and Cellular Biology.
[80] W. Liu,et al. Viral suppression of innate immunity via spatial isolation of TBK1/IKKε from mitochondrial antiviral platform , 2014, Journal of molecular cell biology.
[81] Yi-Ling Lin,et al. Dengue Virus Targets the Adaptor Protein MITA to Subvert Host Innate Immunity , 2012, PLoS pathogens.
[82] P. Sehgal,et al. Interferon-α-induced cytoplasmic MxA structures in hepatoma Huh7 and primary endothelial cells , 2018, Contemporary oncology.
[83] Adolfo García-Sastre,et al. Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling. , 2016, Cell host & microbe.
[84] T. Takimoto,et al. Human parainfluenza virus type 1 but not Sendai virus replicates in human respiratory cells despite IFN treatment. , 2006, Virus research.
[85] Maulik R. Patel,et al. Convergent Evolution of Escape from Hepaciviral Antagonism in Primates , 2012, PLoS biology.
[86] M. Behlke,et al. Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. , 2006, Virology.
[87] T. Takimoto,et al. Antagonism of Innate Immunity by Paramyxovirus Accessory Proteins , 2009, Viruses.
[88] J. Tavernier,et al. Dimerization of the Interferon Type I Receptor IFNaR2–2 Is Sufficient for Induction of Interferon Effector Genes but Not for Full Antiviral Activity* , 1999, The Journal of Biological Chemistry.
[89] C. Spencer,et al. Impact of Interferon Lambda 4 Genotype on Interferon‐Stimulated Gene Expression During Direct‐Acting Antiviral Therapy for Hepatitis C , 2018, Hepatology.
[90] M. Hornef,et al. IFN-λ determines the intestinal epithelial antiviral host defense , 2011, Proceedings of the National Academy of Sciences.
[91] J. Teijaro. Type I interferons in viral control and immune regulation , 2016, Current Opinion in Virology.
[92] C. Power,et al. Zika virus inhibits type‐I interferon production and downstream signaling , 2016, EMBO reports.
[93] Erica Ollmann Saphire,et al. Ebola Virus VP35 Protein Binds Double-Stranded RNA and Inhibits Alpha/Beta Interferon Production Induced by RIG-I Signaling , 2006, Journal of Virology.
[94] B. Williams,et al. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[95] A. García-Sastre,et al. Antagonism of type I interferon by flaviviruses. , 2017, Biochemical and biophysical research communications.
[96] Ren-Jye Lin,et al. Blocking of Interferon-Induced Jak-Stat Signaling by Japanese Encephalitis Virus NS5 through a Protein Tyrosine Phosphatase-Mediated Mechanism , 2006, Journal of Virology.
[97] Kui Li,et al. Coronavirus Papain-like Proteases Negatively Regulate Antiviral Innate Immune Response through Disruption of STING-Mediated Signaling , 2012, PloS one.
[98] Albert C. Huang,et al. Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier , 2015, Science Translational Medicine.
[99] C. Cameron,et al. The 3′ Untranslated Regions of Influenza Genomic Sequences Are 5′PPP-Independent Ligands for RIG-I , 2012, PloS one.
[100] Yuqiong Liang,et al. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor , 2007, Proceedings of the National Academy of Sciences.
[101] J. Rossjohn,et al. Interferon-ε Protects the Female Reproductive Tract from Viral and Bacterial Infection , 2013, Science.
[102] Chao Xing,et al. A CRISPR screen identifies IFI6 as an ER-resident interferon effector that blocks flavivirus replication , 2018, Nature Microbiology.
[103] S. Pestka,et al. Binding and activity of all human alpha interferon subtypes. , 2011, Cytokine.
[104] S. Pellegrini,et al. USP18-Based Negative Feedback Control Is Induced by Type I and Type III Interferons and Specifically Inactivates Interferon α Response , 2011, PloS one.
[105] John Karijolich,et al. RIG-I like receptor sensing of host RNAs facilitates the cell-intrinsic immune response to KSHV infection , 2018, Nature Communications.
[106] A. García-Sastre. Ten Strategies of Interferon Evasion by Viruses , 2017, Cell Host & Microbe.
[107] T. Waldmann,et al. Gene regulation and suppression of type I interferon signaling by STAT3 in diffuse large B cell lymphoma , 2018, Proceedings of the National Academy of Sciences.
[108] Lihan K. Yan,et al. Respiratory syncytial virus infection induces a subset of types I and III interferons in human dendritic cells. , 2017, Virology.
[109] W. Windsor,et al. Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor. , 1995, Nature.
[110] M. Schwemmle,et al. Genome trimming by Borna disease viruses: Viral replication control or escape from cellular surveillance? , 2007, Cellular and Molecular Life Sciences.
[111] O. Sanal,et al. ISG15 deficiency and increased viral resistance in humans but not mice , 2016, Nature Communications.
[112] Xuetao Cao,et al. Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review. , 2017, Journal of autoimmunity.
[113] A. García-Sastre,et al. Arterivirus and Nairovirus Ovarian Tumor Domain-Containing Deubiquitinases Target Activated RIG-I To Control Innate Immune Signaling , 2011, Journal of Virology.
[114] C. Rice,et al. Interferon-stimulated genes: a complex web of host defenses. , 2014, Annual review of immunology.
[115] Limin Chen,et al. MxA is a positive regulator of type I IFN signaling in HCV infection , 2017, Journal of medical virology.
[116] S. Goodbourn,et al. Paramyxovirus V Proteins Interact with the RNA Helicase LGP2 To Inhibit RIG-I-Dependent Interferon Induction , 2012, Journal of Virology.
[117] S. Riaz,et al. Innate Sensing of Influenza A Virus Hemagglutinin Glycoproteins by the Host Endoplasmic Reticulum (ER) Stress Pathway Triggers a Potent Antiviral Response via ER-Associated Protein Degradation , 2017, Journal of Virology.
[118] B. Williams,et al. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays , 1998 .
[119] T. Wolff,et al. Viral targeting of the interferon-β-inducing Traf family member-associated NF-κB activator (TANK)-binding kinase-1 , 2005 .
[120] P. Zhou,et al. Dampened STING-Dependent Interferon Activation in Bats , 2018, Cell Host & Microbe.
[121] S. Pellegrini,et al. Receptor dimerization dynamics as a regulatory valve for plasticity of type I interferon signaling , 2015, The Journal of cell biology.
[122] V. Volchkov,et al. The Ebola virus VP35 protein functions as a type I IFN antagonist. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[123] C. Horvath,et al. Nipah Virus V Protein Evades Alpha and Gamma Interferons by Preventing STAT1 and STAT2 Activation and Nuclear Accumulation , 2002, Journal of Virology.
[124] A. Barrett,et al. The NS5 Protein of the Virulent West Nile Virus NY99 Strain Is a Potent Antagonist of Type I Interferon-Mediated JAK-STAT Signaling , 2010, Journal of Virology.
[125] G. Barber,et al. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity , 2009, Nature.
[126] S. Aguirre,et al. Dengue virus NS2B protein targets cGAS for degradation and prevents mitochondrial DNA sensing during infection , 2017, Nature Microbiology.
[127] Stanley M Lemon,et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[128] Ralf Bartenschlager,et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.
[129] S. Whelan,et al. STING-dependent translation inhibition restricts RNA virus replication , 2018, Proceedings of the National Academy of Sciences.
[130] Zhongbin Chen,et al. SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex , 2014, Protein & Cell.
[131] D. Levy,et al. IFN-Stimulated transcription through a TBP-free acetyltransferase complex escapes viral shutoff , 2002, Nature Cell Biology.
[132] R. Hilgenfeld,et al. RNA‐virus proteases counteracting host innate immunity , 2017, FEBS letters.
[133] Scott R. Presnell,et al. IL-28, IL-29 and their class II cytokine receptor IL-28R , 2002, Nature Immunology.
[134] C. Horvath,et al. Enabled interferon signaling evasion in an immune-competent transgenic mouse model of parainfluenza virus 5 infection. , 2008, Virology.
[135] D. Garcin,et al. IFN-λ prevents influenza virus spread from the upper airways to the lungs and limits virus transmission , 2018, eLife.
[136] L. Ivashkiv,et al. Role of STAT3 in Type I Interferon Responses , 2006, Journal of Biological Chemistry.
[137] Yuqiong Liang,et al. Disruption of TLR3 Signaling Due to Cleavage of TRIF by the Hepatitis A Virus Protease-Polymerase Processing Intermediate, 3CD , 2011, PLoS pathogens.
[138] B. Chain,et al. Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation. , 2009, The Journal of infectious diseases.
[139] G. Schreiber,et al. Receptor Density Is Key to the Alpha2/Beta Interferon Differential Activities , 2009, Molecular and Cellular Biology.
[140] Christopher T. Jones,et al. A diverse array of gene products are effectors of the type I interferon antiviral response , 2011, Nature.
[141] L. Ivashkiv,et al. Regulation of type I interferon responses , 2013, Nature Reviews Immunology.
[142] Fatema Z. Chowdhury,et al. STAT2: A shape-shifting anti-viral super STAT. , 2013, JAK-STAT.
[143] Ren-Jye Lin,et al. Blocking of the Alpha Interferon-Induced Jak-Stat Signaling Pathway by Japanese Encephalitis Virus Infection , 2004, Journal of Virology.
[144] M. Katze,et al. Flavivirus Antagonism of Type I Interferon Signaling Reveals Prolidase as a Regulator of IFNAR1 Surface Expression. , 2015, Cell host & microbe.
[145] K. Shuai,et al. UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity , 2006, The EMBO journal.
[146] Jessica K. Fiege,et al. Distinct antiviral signatures revealed by the magnitude and round of influenza virus replication in vivo , 2018, Proceedings of the National Academy of Sciences.
[147] R. Norton,et al. Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity. , 2012, Immunity.
[148] C. Horvath,et al. Identification of the Nuclear Export Signal and STAT-Binding Domains of the Nipah Virus V Protein Reveals Mechanisms Underlying Interferon Evasion , 2004, Journal of Virology.
[149] Michiel van Gent,et al. Viral unmasking of cellular 5S rRNA pseudogene transcripts induces RIG-I mediated immunity , 2017, Nature Immunology.
[150] C. Horvath,et al. Host evasion by emerging paramyxoviruses: Hendra virus and Nipah virus v proteins inhibit interferon signaling. , 2004, Viral immunology.
[151] B. Damania,et al. The cGAS-STING Defense Pathway and Its Counteraction by Viruses , 2016, Cell Host & Microbe.
[152] K. Takeuchi,et al. Sendai virus C protein physically associates with Stat1 , 2001, Genes to cells : devoted to molecular & cellular mechanisms.
[153] C. Rice,et al. Roles of Nonstructural Protein nsP2 and Alpha/Beta Interferons in Determining the Outcome of Sindbis Virus Infection , 2002, Journal of Virology.
[154] Zejun Li,et al. A Single Mutation at Position 156 in the Envelope Protein of Tembusu Virus Is Responsible for Virus Tissue Tropism and Transmissibility in Ducks , 2018, Journal of Virology.
[155] S. Kotenko,et al. Type III interferon is a critical regulator of innate antifungal immunity , 2017, Science Immunology.
[156] E. Mackow,et al. An Innate Immunity-Regulating Virulence Determinant Is Uniquely Encoded within the Andes Virus Nucleocapsid Protein , 2014, mBio.
[157] Diego Jaitin,et al. Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta. , 2006, Molecular and cellular biology.
[158] M. Albert,et al. Type I and Type III Interferons Drive Redundant Amplification Loops to Induce a Transcriptional Signature in Influenza-Infected Airway Epithelia , 2013, PLoS pathogens.
[159] D. Garcin,et al. Short Double-stranded RNAs with an Overhanging 5′ ppp-Nucleotide, as Found in Arenavirus Genomes, Act as RIG-I Decoys* , 2010, The Journal of Biological Chemistry.
[160] R. Bartenschlager,et al. Comparative Analysis of the Lambda-Interferons IL-28A and IL-29 regarding Their Transcriptome and Their Antiviral Properties against Hepatitis C Virus , 2010, PloS one.
[161] Jeffrey L. Brodsky,et al. One step at a time: endoplasmic reticulum-associated degradation , 2008, Nature Reviews Molecular Cell Biology.
[162] E. Kurt-Jones,et al. Pattern Recognition Receptors and the Innate Immune Response to Viral Infection , 2011, Viruses.
[163] Joshua B. Singer,et al. Fundamental properties of the mammalian innate immune system revealed by multispecies comparison of type I interferon responses , 2017, PLoS biology.
[164] C. Horvath,et al. STAT2 Acts as a Host Range Determinant for Species-Specific Paramyxovirus Interferon Antagonism and Simian Virus 5 Replication , 2002, Journal of Virology.
[165] S. Orkin,et al. ADAR1 is essential for maintenance of hematopoiesis and suppression of interferon signaling , 2008, Nature Immunology.
[166] T. Takimoto,et al. Host specificity of the anti-interferon and anti-apoptosis activities of parainfluenza virus P/C gene products. , 2009, The Journal of general virology.
[167] G. Foster,et al. Dengue Virus Inhibits Alpha Interferon Signaling by Reducing STAT2 Expression , 2005, Journal of Virology.
[168] M. Dallman,et al. Impaired Antiviral Response and Alpha/Beta Interferon Induction in Mice Lacking Beta Interferon , 2000, Journal of Virology.
[169] K. Garcia,et al. The IFN-lambda-IFN-lambda R1-IL-10R beta Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity. , 2017 .
[170] D. Levy,et al. Tissue-specific Positive Feedback Requirements for Production of Type I Interferon following Virus Infection* , 2005, Journal of Biological Chemistry.
[171] Peter O. Krutzik,et al. Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons , 2011, Cell.
[172] E. Ooi,et al. Dengue virus activates cGAS through the release of mitochondrial DNA , 2017, Scientific Reports.